Last reviewed · How we verify
NCT06791473
AI-Driven Cancer Diagnosis and Prediction With EHR
trial testing AI-Based Diagnostic and Prognostic Model in Tumor in 1,000,000 participants. Currently enrolling.
1 October 2025
Quick facts
| Lead sponsor | The Eye Hospital of Wenzhou Medical University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000,000 |
| Start date | 19 January 2025 |
| Primary completion | 1 October 2025 |
| Estimated completion | 1 October 2025 |
| Sites | 7 locations across China |
Drugs / interventions tested
- AI-Based Diagnostic and Prognostic Model
Conditions studied
- Tumor — all drugs for Tumor →
Sponsor
The Eye Hospital of Wenzhou Medical University
Who can join
Adults 0 to 90, any sex, with Tumor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a multi-center, clinical study designed to evaluate the application and effectiveness of an AI-assisted predictive model for identifying and diagnosing cancer, leveraging multimodal health data.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06791473
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tumor
Currently open trials in the same condition.
- NCT07399652 — Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures · NA · recruiting
- NCT07382752 — Decoupling Immunotherapy Toxicity and Cancer Response · recruiting
- NCT07464132 — Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases · Phase 1, PHASE2 · recruiting
- NCT07144085 — Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases. · Phase 1 · recruiting
- NCT07147465 — Performance Indicators and Impact on the Care Pathway of Sequencing on the SeqOIA and AURAGEN (Seqogen) Platforms for On · recruiting
Other The Eye Hospital of Wenzhou Medical University trials
Trials by the same sponsor.
- NCT06755060 — Ophthalmic AI-Assisted Medical Decision-Making · NA · recruiting
- NCT07092085 — AI-Powered Mental Health Screening in University Students · completed
- NCT06791486 — AI-Driven Prediction of Biological Age With EHR · recruiting
- NCT03968575 — Sub-threshold Micro-Pulse Laser Therapy for Drusen of Dry AMD · NA · unknown
- NCT03433885 — Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06791473 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Eye Hospital of Wenzhou Medical University
- Last refreshed: 30 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06791473.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing